Ibogaine brain mapping study for opioid use disorder
Part of Mental health clinical trials.
This study uses MRI and EEG scans to map how ibogaine affects the brain in people with opioid use disorder. You must already be scheduled to receive ibogaine treatment in Tijuana, Mexico, on your own, as the study does not cover treatment costs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 to 70 years old
- You have moderate to severe opioid use disorder (based on DSM-5 criteria)
- You are already scheduled to receive ibogaine treatment at Ambio Life Sciences in Tijuana, Mexico
- You can undergo MRI and EEG scans at UC Irvine at three different times
- You can provide urine samples and complete surveys at study visits
- You speak, read, and write English well enough to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding cannabidiol (CBD) to your usual methadone or buprenorphine treatment helps you recover from opioid use disorder. If you're already in stable treatment with those medications, the trial aims to see if CBD can improve your outcomes.
This study tests a new type of brain stimulation that adapts to your brain activity, aiming to reduce cravings and help you control opioid use. It is for people with long-standing opioid use disorder who have not gotten lasting relief from at least 3 treatment attempts, including medication.
This study uses brain wave recordings (EEG) to understand opioid use disorder and find better ways to diagnose and treat it. You may join if you have opioid use disorder or are a healthy volunteer.
This study uses MRI scans over time to track brain changes in people with opioid use disorder who recently started methadone treatment. You can help researchers understand recovery patterns if you are early in your methadone journey and can commit to repeated visits.
This study uses brain scans to understand how adversity affects opioid use and recovery. It compares people with opioid use disorder on buprenorphine, people taking buprenorphine for chronic pain, and healthy volunteers.
This study uses brain scans to understand how methadone or buprenorphine treatment affects the brain, with the goal of helping people stay in treatment and avoid relapse. You would need to be recently started on one of these medications and be able to undergo MRI scans.
Hear when a new Opioid Use Disorder (OUD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.